Steven Cohen Amneal Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $317,020 - $383,570	60,500 New	60,500 $366,000
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $342,240 - $569,160	124,000 New	124,000 $523,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $1.44 Million - $2.59 Million	-714,900 Reduced 20.63%	2,750,000 $5.56 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $1.4 Million - $2.08 Million	466,020 Added 15.54%	3,464,900 $11 Million
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $1.22 Million - $1.53 Million	-312,520 Reduced 9.44%	2,998,880 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $1.71 Million - $2.54 Million	-433,600 Reduced 11.58%	3,311,400 $15.9 Million
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $8.28 Million - $10.8 Million	1,920,196 Added 105.23%	3,745,000 $20 Million
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $5.67 Million - $7.55 Million	-1,107,096 Reduced 37.76%	1,824,804 $9.34 Million
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $13.9 Million - $21.6 Million	2,931,900 New	2,931,900 $19.7 Million
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $2.68 Million - $5.63 Million	-1,011,800 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$2.29 - $7.1 $5.28 Million - $16.4 Million	-2,303,660 Reduced 69.48%	1,011,800 $2.93 Million
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $21.4 Million - $47.4 Million	3,315,460 New	3,315,460 $23.8 Million
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $10.5 Million - $17.2 Million	-800,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $13.1 Million - $19.4 Million	800,000 New	800,000 $17.8 Million

186

137M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.24B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.